Skip to main content

Published locations for PARP inhibitor prolongs PFS in ovarian cancer patients with and without BRCA mutations

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. PARP inhibitor prolongs PFS in ovarian cancer patients with and without BRCA mutations

User login

  • Reset your password
  • /content/parp-inhibitor-prolongs-pfs-ovarian-cancer-patients-and-without-brca-mutations
  • /obgynnews/article/115513/gynecologic-cancer/parp-inhibitor-prolongs-pfs-ovarian-cancer-patients-and
  • /oncologypractice/article/115513/gynecologic-cancer/parp-inhibitor-prolongs-pfs-ovarian-cancer
  • /obgyn/article/115513/gynecologic-cancer/parp-inhibitor-prolongs-pfs-ovarian-cancer-patients-and
  • /hematology-oncology/article/115513/gynecologic-cancer/parp-inhibitor-prolongs-pfs-ovarian-cancer